HC Wainwright & Co. Reiterates Buy on Immunome, Maintains $40 Price Target

Immunome, Inc.

Immunome, Inc.

IMNM

0.00

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Immunome (NASDAQ: IMNM) with a Buy and maintains $40 price target.